Endothelial and neuronal engagement by AAV-BR1 gene therapy alleviates neurological symptoms and lipid deposition in a mouse model of Niemann-Pick type C2

Related articles

1. Vascular dysfunction in Huntington’s disease is located at the blood-CSF barrier and is rescued by sphingosine-1-phosphate receptor agonist

   This article has 9 authors:

   1. Krzysztof Kucharz
   2. Rana Soylu-Kucharz
   3. Martine Saint-Pierre
   4. Melanie Alpaugh
   5. Filippa L. Qvist
   6. Maria Björkqvist
   7. Niels Henning Skotte
   8. Francesca Cicchetti
   9. Martin Lauritzen

2. Glial-specific and inducible full body C3 deficiency does not affect amyloid pathology in the AppNL-G-F mouse model of Alzheimer’s disease

   This article has 12 authors:

   1. Pieter Dujardin
   2. Joyce Foroozandeh
   3. Roselien Verhaegen
   4. Marlies Burgelman
   5. Clint De Nolf
   6. Elien Wonterghem
   7. Griet Imschoot
   8. Wouter Peelaerts
   9. Tino Hochepied
   10. Lien Van Hoecke
   11. Charysse Vandendriessche
   12. Roosmarijn E Vandenbroucke

3. In vivo validation of novel non-invasive PHP.eB AAVs as a potential therapeutic approach for alpha-Synucleinopathies

   This article has 11 authors:

   1. Maria Fouka
   2. Iraklis Tsakogias
   3. Elena-Georgia Gialinaki
   4. Athanasios Stavropoulos
   5. Christiane Volbracht
   6. Louis De Muynck
   7. Diederik Moechars
   8. Ronald Melki
   9. George K. Tofaris
   10. Leonidas Stefanis
   11. Maria Xilouri